Calumet, Inc.
49.305USD
-0.0150 (-0.03%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CLMT.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,445 | 1,030 | 1,039 | 1,078 | 1,027 | 994 | 950 | 1,100 |
| Cost of Revenue | 1,427 | 1,117 | 1,042 | 704 | 1,070 | 1,075 | 866 | 1,096 |
| Gross Profit | 18 | -88 | -3 | 374 | -44 | -81 | 84 | 5 |
| Operating Income | -40 | -171 | -65 | 323 | -101 | -49 | 23 | -57 |
| Net Income | -96 | -317 | -37 | 313 | -148 | -162 | -41 | -101 |
| EPS (Diluted) | -$1.09 | -$3.64 | -$0.43 | $3.61 | -$1.70 | -$1.87 | -$0.46 | -$1.18 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)